Unlike its function in other death modes, PGAM5, an integral protein, in oxeiptosis is mediated by KEAP1PGAM5AIFM1, in which PGAM5 dephosphorylates AIFM1 (ref
Chronic NSAID use increases risk 40-fold, with symptoms potentially developing within days of starting ibuprofen, naproxen, or aspirin at therapeutic doses
Book a consultation with us to find out more
Atkinson, S
The nanocomposite architecture ensures sustained drug release, prolonged half-life, and enhanced tissue penetration, collectively mitigating gouty inflammation and preventing urate crystal-induced nephropathy ( Additionally, PEGdrug conjugates are prevalent functionalized carriers where PEG modifies therapeutic agents (e.g., uricase) to improve pharmacokinetics and reduce immunogenicity ( 4.3.3 Hydrogel and fibrous polymeric carrier systems Hydrogel and fibrous polymeric carrier systems enable precise targeting and multi-mechanistic synergies in gout therapeutics through localized delivery, sustained release, and environmental responsiveness, thereby enhancing efficacy while reducing adverse effects
Possesses antioxidant properties that combat oxidative stress and inflammation
